Researchers report on the long-term immune changes in patients with refractory or relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax and rituximab plus bendamustine and rituximab.
Lucknow: The state capital officially recorded its first dengue death of the year on Friday, raising concerns among health officials and residents. Shreyansh Srivastava, an 18-year-old resident of ...
Rapid Response Team of Maharashtra meets representatives of private hospitals in Pune on Thursday following reports of rise ...